Table 2

Comparison of sensitivity to chemotherapy in patient versus xenotransplant

Xenotransplant (T/C)aPatient
SarcomaDoxorubicinIfosfamideChemotherapy withResult
401329b10bIfosfamideP
412639135ND
41498868Doxorubicin, ifosfamidePR for 6 mos
418321b7bND
425490163Epirubicin, ifosfamide, vincristineP
42906233Doxorubicin, ifosfamidePR >4 mos
442039b28bDoxorubicin, ifosfamideSD for 5 mos
44484b45Doxorubicin, ifosfamideSD for 6 mos
456114b85Doxorubicin, ifosfamideSD for 15 mos
460525b7bCyclophosphamide, doxorubicin, vincristine, cisplatinCR for 36 mos
46182614ND
467916970Epirubicin, ifosfamideCR >2 mos
480917b42ND
49175332bND
  • a T/C, tumor volume treated group/tumor volume control group × 100%; CR, complete remission; PR, partial remission; SD, stable disease; P, progression; ND, not done; NE, not evaluable.

  • b Significant.